Streetbeat News

Stock Prices

SIGA

The National Institutes of Health's National Institute of Allergy and Infectious Diseases announced that the PALM 007 trial of Tecovirimat for Monkeypox virus did not meet its primary endpoint. The study showed no statistically significant improvement in time to lesion resolution within 28 days post-randomization for patients in Congo versus placebo.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:39 am

DFLI

Dragonfly Energy Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:36 am

BA

GCAD

ITA

Boeing Company (NYSE:BA) has finalized a deal with EL AL Israel Airlines for up to 31 737 MAX jets, valued at up to $2.5 billion. This deal supports EL AL's fleet renewal plans and aims to improve fuel efficiency, environmental performance, and passenger comfort. Boeing shares are trading higher premarket. Investors can gain exposure to Boeing via IShares U.S. Aerospace & Defense ETF (BATS:ITA) and Gabelli Commercial Aerospace and Defense ETF (NYSE:GCAD).

Portfolio Pulse from Lekha Gupta

August 15, 2024 | 11:36 am

ELTK

Eltek (NASDAQ:ELTK) reported Q2 earnings per share of $0.11, missing the analyst estimate of $0.25 by 56%. Sales were $10.47M, missing the $11.90M estimate by 12.05%. Both earnings and sales decreased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:34 am

FFIE

Faraday Future reported its Q2 2024 GAAP EPS at $(0.31), which may not be comparable to the $(3.87) estimate. The company also reported sales of $293,000, which may not be comparable to the $4.25 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:33 am

SIGA

Trading for SIGA Technologies, Inc. (SIGA) was halted at 7:30:00 a.m. ET pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:30 am

CSCO

GOOGL

LITE

NKE

QQQ

SPY

WMT

U.S. stocks are poised for a modestly higher start, with the S&P 500 aiming for a sixth consecutive win. Key data on job market, consumer spending, and manufacturing activity, along with retail earnings, will influence trading. Walmart's strong earnings and guidance boost shares, while Alphabet faces potential DOJ action. Cisco and Lumentum see premarket gains on positive earnings. Upcoming economic data and Fed speeches will be closely watched.

Portfolio Pulse from Shanthi Rexaline

August 15, 2024 | 11:29 am

BLRX

BioLine Rx reported Q2 2024 GAAP EPS of $0.00, beating the estimate of $(0.14). Sales were $5.393M, surpassing the $3.930M estimate.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:28 am

AEMD

Aethlon Medical shares are trading lower following worse-than-expected Q1 EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:26 am

CLBT

Cellebrite has increased its 2024 revenue outlook from $370M-$380M to $390M-$398M, surpassing the estimated $378.306M. The company also projects Q3 revenue of $100M-$104M, exceeding the estimated $94.77M.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:26 am